Genomic diversity contributes to the neuroinvasiveness of the Yellow fever French neurotropic vaccine
Abstract Mass vaccination with the live attenuated vaccine YF-17D is the current way to prevent infection with Yellow fever virus (YFV). However, 0.000012–0.00002% of vaccinated patients develop post-vaccination neurological syndrome (YEL-AND). Understanding the factors responsible for neuroinvasion...
Guardado en:
Autores principales: | Florian Bakoa, Christophe Préhaud, Guillaume Beauclair, Maxime Chazal, Nathalie Mantel, Monique Lafon, Nolwenn Jouvenet |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3250ab5afc1042ee8bd3d7363697f181 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Vaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune Responses
por: Maria Dolores Fernandez-Garcia, et al.
Publicado: (2016) -
Comparative analysis of neuroinvasion by Japanese encephalitis virulent and vaccine viral strains in an in vitro model of human blood-brain barrier.
por: Cécile Khou, et al.
Publicado: (2021) -
Incubation Period for Neuroinvasive Toscana Virus Infections
por: Lison Laroche, et al.
Publicado: (2021) -
An updated antennal lobe atlas for the yellow fever mosquito Aedes aegypti.
por: Shruti Shankar, et al.
Publicado: (2020) -
Yellow fever vaccine protects mice against Zika virus infection.
por: Ana C Vicente Santos, et al.
Publicado: (2021)